Replay available

Beta Bionics, Inc. (BBNX) Q2 2026 Earnings Call

Beta Bionics, Inc. (NASDAQ: BBNX) Q2 2026 earnings conference call, held 2026-07-29. Replay captured from the company's public earnings webcast.

Wed, July 29, 2026 at 4:30 PMendedReplay
Beta Bionics, Inc. (BBNX) Q2 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Blake Deber

Head of Investor Relations at Beta Bionics

Sean Saint

Chief Executive Officer at Beta Bionics

Steven Feider

Chief Financial Officer at Beta Bionics

Richard Newitter

at TruSecurities

Matthew O'Brien

at Piper Sandler

Patrick Wood

at UBS

Jordan Bernstein

at Stifel

Mike Kratky

at Leerink Partners

Matthew Blackman

at TD Cowen

Jeff Thompson

at R

Michael Polaruk

at Wolfe Research

Stephanie Argali

at Bank of America

Jeffrey Cohen

at Ladenburg Thalmann

Frank Taganan

at Lake Street Capital Markets

Replay transcript excerpt

Good afternoon, and welcome to the Beta Bionics Second Quarter twenty twenty six Earnings Conference Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session, and instructions will follow at that time. As a reminder, please be advised that today's conference is being recorded. I would now like to hand the conference over to Blake Deber, Head of Investor Relations. Good afternoon, and thank you for joining Beta Bionics' Second Quarter twenty twenty six Earnings Call. With me on today's call are Chief Executive Officer, Sean Saint and Chief Financial Officer, Steven Feider. Both the replay of this call and the press release discussing our second quarter twenty twenty six results will be available on the Investor Relations section of our website. Information recorded on this call speaks only as of today, 07/29/2026. Therefore, if you are listening to a replay, any time sensitive information may no longer be accurate. Also on our website is our supplemental second quarter twenty twenty six earnings presentation and uploaded corporate presentation. We encourage you to refer to those documents for a summary of key metrics and business updates. Before we begin, we would like to remind you that today's discussion will include forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements reflect management's expectations about future events, our product pipeline, development timelines, financial performance and operating plans. Please refer to the cautionary statements in the press release we issued earlier today for a detailed explanation of the inherent limitations of such forward looking statements. These documents contain and ident...

More from Beta Bionics, Inc.